Tolterodine Tartrate Capsule, Extended Release
Product Images NDC 70436-161

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 70436-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2mg-30ct (2mg 30ct)

2mg-30ct (2mg 30ct)
Tolterodine Tartrate Extended-Release Capsules 2 mg, oral dosage form, packaging label showing 30 capsules. Label includes storage instructions, manufacturer Yichang Humanwell Oral Solid Dosage Plant, and distributor Slate Run Pharmaceuticals, LLC. The package is labeled Rx only and includes a barcode and lot/serialization area.*
FDA Label Image

2mg-500ct (2mg 500ct)

2mg-500ct (2mg 500ct)
Label for Tolterodine Tartrate Extended-Release Capsules, 2 mg, by Slate Run Pharmaceuticals, LLC. The label includes NDC 70436-160-02, storage instructions at 20° to 25°C, manufacturer details in Yichang, China, and a quantity of 500 capsules. The label also notes child-resistant container requirements and usual dosage reference to package insert.*
FDA Label Image

2mg-90ct (2mg 90ct)

2mg-90ct (2mg 90ct)
Tolterodine Tartrate Extended-Release Capsules 2 mg oral dosage form, supplied by Slate Run Pharmaceuticals, LLC. The package contains 90 capsules. The label includes storage instructions, child-resistance information, and directions to consult the package insert for full prescribing information. Manufactured by Yichang Humanwell Oral Solid Dosage Plant in Hubei, China, and distributed by Slate Run Pharmaceuticals in Columbus, Ohio.*
FDA Label Image

4mg-30ct (4mg 30ct)

4mg-30ct (4mg 30ct)
Label for Tolterodine Tartrate Extended-Release Capsules, 4 mg strength, by Slate Run Pharmaceuticals, LLC. The package contains 30 capsules. The label includes dosage form as extended-release capsules, storage instructions, manufacturer and distributor information, a barcode, and notes on child resistance and light protection.*
FDA Label Image

4mg-500ct (4mg 500ct)

4mg-500ct (4mg 500ct)
Tolterodine Tartrate Extended-Release Capsules 4 mg oral capsules, labeled for 500 count, manufactured by Yichang Humanwell Oral Solid Dosage Plant, distributed by Slate Run Pharmaceuticals, LLC. The label includes storage instructions, dosage guidance, a barcode, and the NDC number 70436-161-02.*
FDA Label Image

4mg-90ct (4mg 90ct)

4mg-90ct (4mg 90ct)
Label for Tolterodine Tartrate Extended-Release Capsules 4 mg by Slate Run Pharmaceuticals, LLC. The label states the product is prescription only and contains 90 capsules. It includes storage instructions, dosage warnings, manufacturer and distributor details, and a barcode. A designated coating-free area for lot and serialization data is also visible.*
FDA Label Image

Chemical Structure (Detrol La 01)

Chemical Structure (Detrol La 01)
Chemical structure of Tolterodine Tartrate showing the molecular arrangement of its chemical groups, including the tolterodine base and tartrate moiety.*
FDA Label Image

Ink1 (Ink1)

Ink1 (Ink1)
Tolterodine Tartrate extended release capsules, 2 mg and 4 mg strengths, packaged in a white box with black text. The label displays the generic name and dosage form, with the Slate Run Pharmaceuticals, LLC labeler name visible. The packaging includes a blister pack containing capsules.*
FDA Label Image

Ink2 (Ink2)

Ink2 (Ink2)
Tolterodine Tartrate 2 mg extended release capsules packaging label. The label features the product name and strength prominently, includes a green and white color scheme, and the labeler Slate Run Pharmaceuticals, LLC. The dosage form is oral extended release capsules.*
FDA Label Image

Ink3 (Ink3)

Ink3 (Ink3)
Tolterodine Tartrate 4 mg extended release capsules in a transparent plastic blister pack containing 28 capsules. Each capsule is colored orange and white with imprint visible. Manufactured or labeled by Slate Run Pharmaceuticals, LLC.*
FDA Label Image

Ink4 (Ink4)

Ink4 (Ink4)
Tolterodine Tartrate 2 mg extended release capsules in a blister pack. The image shows capsules with pink and beige colors in a silver foil blister packaging. The brand or labeler, Slate Run Pharmaceuticals, LLC, is not visible on the pack itself.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.